Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: JW Holdings Corporation

JW Holdings Corporation (096760.KS)

Industry: Drug Manufacturers - Specialty & Generic Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $8,876.41 — $36,525.97
Selected (Average) $19,416.58
Upside to Live 441.61%
Full Range Fair Value
Range (Low - High) $9,528.21 — $40,865.26
Selected (Average) $22,644.58
Upside to Live 531.65%
Live Price $3,585.00

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
LAURUSLABS.BO 116 Laurus Labs Limite 704 66.44 64.67 32.13 29.60 42.08 20.12
4534.T 117 Mochida Pharmaceut 701 16.76 16.05 5.10 5.10 6.33 6.59
003850.KS 118 Boryung Corporatio 691 17.67 17.23 8.45 7.92 7.70 9.99
SNDL 119 SNDL Inc. 690 - - - - - -
ITCI 120 Intra-Cellular The 681 - - - - - -
002773.SZ 121 Chengdu Kanghong P 662 27.28 24.60 20.41 18.11 22.34 18.98
001630.KS 122 Chong Kun Dang Hol 644 6.41 7.07 3.44 3.12 9.92 15.04
096760.KS 123 JW Holdings Corpor 634 5.20 5.20 1.80 1.16 2.85 3.34
600750.SS 124 Jiang Zhong Pharma 624 16.43 14.70 11.39 10.28 15.80 9.64
086450.KQ 125 DongKook Pharmaceu 606 13.83 13.95 7.22 6.95 8.71 9.48
HAEK.DE 126 Haemato AG 605 12.02 12.09 5.93 5.64 5.18 5.47
2HQ.DE 127 Tilray Brands, Inc 603 - - - - 234.37 -
4547.T 128 Kissei Pharmaceuti 589 12.30 9.96 7.58 6.72 - -
000153.SZ 129 Anhui Fengyuan Pha 588 26.38 24.36 24.05 25.66 72.99 32.39
3737.HK 130 Zhongzhi Pharmaceu 575 5.35 5.63 3.02 3.04 34.73 4.78
084110.KQ 131 Huons Global Co., 559 22.93 24.49 1.93 1.55 7.83 6.36

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple15.1314.326.586.189.329.48
Full Range Median Multiple16.5915.387.406.8312.869.64
Industry Multiple20.3219.5710.8910.3139.0012.62
Market Implied Multiple5.795.791.891.222.983.50
Company (096760.KS) Multiple5.205.201.801.162.853.34
(*) Net Income / EBITDA / Revenue2929202313128109
Winsorized Enterprise ValueN/AN/A1,3271,9361,1901,032
Full Range Median Enterprise ValueN/AN/A1,4932,1411,6431,049
(-) Net Debt212212212212212212
Winsorized Equity Value4434191,1151,724979820
Full Range Median Equity Value4854501,2811,9291,431838
(/) Shares Outstanding000000
Winsorized Fair Value$9,375.05$8,876.41$23,622.70$36,525.97$20,727.74$17,371.61
Full Range Median Fair Value$10,282.78$9,528.21$27,139.71$40,865.26$30,311.17$17,740.38
Current Price$3,585.00$3,585.00$3,585.00$3,585.00$3,585.00$3,585.00
Upside / Downside161.51%147.60%558.93%918.86%478.18%384.56%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$6,562.54$6,213.49$16,535.89$25,568.18$14,509.42$12,160.13
Buy / Don't BuyBUYBUYBUYBUYBUYBUY